Should Direct to Consumer Advertisements (DTCA) of Prescription Drugs Remain Banned in Malaysia?
Advertisements for prescription drugs directed at consumers can empower consumers by providing information on potential treatments for their ailments. Ideally, this information may also enable them to make informed decisions, lead to an early diagnosis or treatment of illnesses, or assist in their discussions with physicians. It has been argued, however, that information in such advertisements is, among other things, biased, misleading and causes unnecessary medication. Such advertising is currently prohibited in Malaysia. It is, however, permitted in the United States of America, New Zealand, and Canada, although under different constraints. This article explores the benefits and the detriments of advertising prescription drugs directly to consumers. It also examines the existing regulatory control of medicines in Malaysia and argues that Malaysia, should maintain its existing approach
Year of publication: |
2016
|
---|---|
Authors: | Marimuthu, Siva Barathi |
Publisher: |
[2016]: [S.l.] : SSRN |
Subject: | Malaysia | Arzneimittel | Pharmaceuticals | Werbung | Advertising | Direktmarketing | Direct marketing | Werbewirkung | Advertising effects | Konsumentenverhalten | Consumer behaviour |
Saved in:
freely available
Extent: | 1 Online-Ressource (14 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: Australian Journal of Asian Law, Vol. 17, No. 1, Article 6, Pp. 1-14, 2016 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments June 29, 2016 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012987820
Saved in favorites
Similar items by subject
-
The impact of direct-to-consumer advertising on health insurance markets
Encinosa, William E., (2014)
-
Fogel, Joshua, (2014)
-
Aikin, Kathryn J., (2021)
- More ...
Similar items by person
-
Marimuthu, Siva Barathi, (2021)
- More ...